{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T06:29:55Z","timestamp":1764224995152},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacoeconomics"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.2165\/11535200-000000000-00000","type":"journal-article","created":{"date-parts":[[2010,4,22]],"date-time":"2010-04-22T06:25:19Z","timestamp":1271917519000},"page":"555-566","source":"Crossref","is-referenced-by-count":25,"title":["The Cost of Relapse for Patients with a Manic\/Mixed Episode of Bipolar Disorder in the EMBLEM Study"],"prefix":"10.1007","volume":"28","author":[{"given":"Jihyung","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Reed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"Novick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josep Maria","family":"Haro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Windmeijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Knapp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,9,23]]},"reference":[{"key":"28070555_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1001\/archpsyc.65.4.386","volume":"65","author":"LL Judd","year":"2008","unstructured":"Judd LL, Schettler PJ, Akiskal HS, et al. Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse\/recurrence. Arch Gen Psychiatry 2008; 65: 386\u201394","journal-title":"Arch Gen Psychiatry"},{"key":"28070555_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.euroneuro.2005.04.011","volume":"15","author":"S Pini","year":"2005","unstructured":"Pini S, de Queiroz V, Pagnin D, et al. Prevalence and burden of bipolar disorders in European countries. Eur Neuropsychopharmacol 2005; 15: 425\u201334","journal-title":"Eur Neuropsychopharmacol"},{"issue":"6","key":"28070555_CR3","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2165\/00019053-200523060-00005","volume":"23","author":"DA Revicki","year":"2005","unstructured":"Revicki DA, Matza LS, Flood E, et al. Bipolar disorder and health-related quality of life: review of burden of disease and clinical trials. Pharmacoeconomics 2005; 23 (6): 583\u201394","journal-title":"Pharmacoeconomics"},{"key":"28070555_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0140-6736(02)07450-0","volume":"359","author":"B Muller-Oerlinghausen","year":"2002","unstructured":"Muller-Oerlinghausen B, Berghofer A, Bauer M. Bipolar disorder. Lancet 2002; 359: 241\u20137","journal-title":"Lancet"},{"key":"28070555_CR5","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1034\/j.1399-5618.2001.30403.x","volume":"3","author":"F Cassidy","year":"2001","unstructured":"Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001; 3: 181\u20138","journal-title":"Bipolar Disord"},{"key":"28070555_CR6","volume-title":"Bipolar disorders in CORE PSYCHIATRY","author":"P Mackin","year":"2004","unstructured":"Mackin P, Young AH. Bipolar disorders in CORE PSYCHIATRY. London: Saunders, 2004"},{"key":"28070555_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1192\/bjp.180.3.227","volume":"180","author":"R Gupta Das","year":"2002","unstructured":"Das Gupta R, Guest JF. Annual cost of bipolar disorder to UK society. Br J Psychiatry 2002; 180: 227\u201333","journal-title":"Br J Psychiatry"},{"key":"28070555_CR8","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1007\/s00115-004-1691-x","volume":"75","author":"C Runge","year":"2004","unstructured":"Runge C, Grunze H. Annual costs of bipolar disorders in Germany. Nervenarzt 2004; 75: 896\u2013903","journal-title":"Nervenarzt"},{"key":"28070555_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1001\/archpsyc.60.2.145","volume":"60","author":"DH Lam","year":"2003","unstructured":"Lam DH, Watkins ER, Hayward P, et al. A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry 2003; 60: 145\u201352","journal-title":"Arch Gen Psychiatry"},{"key":"28070555_CR10","volume-title":"Cochrane Database Syst Rev","author":"A Cipriani","year":"2009","unstructured":"Cipriani A, Rendell JM, Geddes J. Olanzapine in long-term treatment for bipolar disorder. Cochrane Database Syst Rev 2009; CD004367"},{"key":"28070555_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/bmj.324.7329.61","volume":"324","author":"R Morriss","year":"2002","unstructured":"Morriss R, Marshall M, Harris A. Bipolar affective disorder: left out in the cold. Too late for the national service framework but local initiatives may be possible. BMJ 2002; 324: 61\u20132","journal-title":"BMJ"},{"issue":"Suppl.10","key":"28070555_CR12","first-page":"13","volume":"63","author":"PE Keck Jr","year":"2002","unstructured":"Keck Jr PE, McElroy SL. Carbamazepine and valproate in the maintenance treatment of bipolar disorder. J Clin Psychiatry 2002; 63 Suppl. 10: 13\u20137","journal-title":"J Clin Psychiatry"},{"key":"28070555_CR13","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1017\/S1461145706006900","volume":"10","author":"J Scott","year":"2007","unstructured":"Scott J, Colom F, Vieta E. A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders. Int J Neuropsychopharmacol 2007; 10: 123\u20139","journal-title":"Int J Neuropsychopharmacol"},{"key":"28070555_CR14","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1034\/j.1399-5618.2002.01148.x","volume":"4","author":"L Bryant-Comstock","year":"2002","unstructured":"Bryant-Comstock L, Stender M, Devercelli G. Health care utilization and costs among privately insured patients with bipolar I disorder. Bipolar Disord 2002; 4: 398\u2013405","journal-title":"Bipolar Disord"},{"issue":"5Pt1","key":"28070555_CR15","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2165\/00019053-200119050-00004","volume":"19","author":"CE Begley","year":"2001","unstructured":"Begley CE, Annegers JF, Swann AC, et al. The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998. Pharmacoeconomics 2001; 19 (5 Pt 1): 483\u201395","journal-title":"Pharmacoeconomics"},{"issue":"15","key":"28070555_CR16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.2165\/00019053-200321150-00002","volume":"21","author":"M Zelicourt de","year":"2003","unstructured":"de Zelicourt M, Dardennes R, Verdoux H, et al. Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France. Pharmacoeconomics 2003; 21 (15): 1081\u201390","journal-title":"Pharmacoeconomics"},{"key":"28070555_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1399-5618.2007.00325.x","volume":"9","author":"I Goetz","year":"2007","unstructured":"Goetz I, Tohen M, Reed C, et al. Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord 2007; 9: 45\u201352","journal-title":"Bipolar Disord"},{"key":"28070555_CR18","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1600-0447.2005.00692.x","volume":"113","author":"JM Haro","year":"2006","unstructured":"Haro JM, van Os J, Vieta E, et al. Evidence for three distinct classes of \u2018typical\u2019, \u2018psychotic\u2019 and \u2018dual\u2019 mania: results from the EMBLEM study. Acta Psychiatr Scand 2006; 113: 112\u201320","journal-title":"Acta Psychiatr Scand"},{"key":"28070555_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0165-1781(97)00123-6","volume":"73","author":"MK Spearing","year":"1997","unstructured":"Spearing MK, Post RM, Leverich GS, et al. Modification of the Clinical Global Impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res 1997; 73: 159\u201371","journal-title":"Psychiatry Res"},{"key":"28070555_CR20","volume-title":"Unit costs of health and social care 2008","author":"L Curtis","year":"2008","unstructured":"Curtis L. Unit costs of health and social care 2008. Kent: University of Kent, 2008"},{"key":"28070555_CR21","unstructured":"British national formulary: BNF 55. 2008 Mar [online]. Available from URL: http:\/\/www.bnf.org\/bnf\/ [Accessed 2008 Apr 15]"},{"key":"28070555_CR22","unstructured":"IMS Health Inc. MIDAS\u00ae. Q4\/2007"},{"key":"28070555_CR23","volume-title":"Full guideline [commissioned by the National Institute for Health and Clinical Excellence]","author":"National Collaborating Centre for Mental Health","year":"2006","unstructured":"National Collaborating Centre for Mental Health. Bipolar disorder: the management of bipolar disorder in adults, children and adolescents, in primary and secondary care. Full guideline [commissioned by the National Institute for Health and Clinical Excellence]. London: NICE, 2006 Jul [online]. Available from URL: http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG38fullguideline.pdf [Accessed 2010 Feb 15]"},{"key":"28070555_CR24","volume-title":"The Maudsley 20052006 prescribing guidelines","author":"D Taylor","year":"2005","unstructured":"Taylor D, Paton C, Kerwin R. The Maudsley 20052006 prescribing guidelines. 8th ed. London: Taylor & Francis, 2005","edition":"8th ed"},{"issue":"Suppl.5","key":"28070555_CR25","first-page":"5","volume":"9","author":"M Lader","year":"1995","unstructured":"Lader M. What is relapse in schizophrenia? Int Clin Psychopharmacol 1995; 9 Suppl. 5: 5\u20139","journal-title":"Int Clin Psychopharmacol"},{"key":"28070555_CR26","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","volume":"56","author":"D Robinson","year":"1999","unstructured":"Robinson D, Woerner MG, Alvir JMJ, et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1999; 56: 241\u20137","journal-title":"Arch Gen Psychiatry"},{"key":"28070555_CR27","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1162\/rest.88.4.641","volume":"88","author":"JMC Santos-Silva","year":"2006","unstructured":"Santos-Silva JMC, Tenreyro S. The log of gravity. Rev Econ Stat 2006; 88: 641\u201358","journal-title":"Rev Econ Stat"},{"key":"28070555_CR28","volume-title":"Diagnostic and statistical manual ofmental disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association. Diagnostic and statistical manual ofmental disorders. 4th ed, text revision (DSM-IVTR). Washington, DC: APA, 2000","edition":"4th ed"},{"key":"28070555_CR29","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-4541-9","volume-title":"An introduction to the bootstrap","author":"B Efron","year":"1993","unstructured":"Efron B. An introduction to the bootstrap. New York: Chapman & Hall, 1993"},{"key":"28070555_CR30","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/S0167-6296(97)00002-7","volume":"16","author":"ST Mennemeyer","year":"1997","unstructured":"Mennemeyer ST, Cyr LP. A bootstrap approach to medical decision analysis. J Health Econ 1997; 16: 741\u20137","journal-title":"J Health Econ"},{"key":"28070555_CR31","doi-asserted-by":"publisher","DOI":"10.1201\/9781439821862","volume-title":"Analysis of incomplete multivariate data","author":"J Schafer","year":"1997","unstructured":"Schafer J. Analysis of incomplete multivariate data. London: Chapman & Hall, 1997"},{"key":"28070555_CR32","volume-title":"Statistical analysis with missing data","author":"R Little","year":"1987","unstructured":"Little R, Rubin D. Statistical analysis with missing data. New York: John Wiley, 1987"},{"key":"28070555_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"D Rubin","year":"1987","unstructured":"Rubin D. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons, 1987"},{"key":"28070555_CR34","volume-title":"Stata statistical software: release 10","author":"Stata Corp","year":"2007","unstructured":"Stata Corp. Stata statistical software: release 10. College Station (TX): StataCorp LP, 2007"},{"key":"28070555_CR35","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1097\/00004850-200209000-00003","volume":"17","author":"L Shi","year":"2002","unstructured":"Shi L, Namjoshi MA, Zhang F, et al. Olanzapine versus haloperidol in the treatment of acute mania: clinical outcomes, health-related quality of life and work status. Int Clin Psychopharmacol 2002; 17: 227\u201337","journal-title":"Int Clin Psychopharmacol"},{"key":"28070555_CR36","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1185\/030079906X104632","volume":"22","author":"L Shi","year":"2006","unstructured":"Shi L, Juarez R, Hackworth J, et al. Open-label olanzapine treatment in bipolar I disorder: clinical and work functional outcomes. Curr Med Res Opin 2006; 22: 961\u20136","journal-title":"Curr Med Res Opin"},{"key":"28070555_CR37","first-page":"1","volume":"8","author":"I Goetz","year":"2006","unstructured":"Goetz I, Tohen M, Reed C, et al. Functional impairment in patients with mania: baseline results of the EMBLEM study. Bipolar Disord 2006; 8: 1\u20138","journal-title":"Bipolar Disord"},{"key":"28070555_CR38","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF00789056","volume":"30","author":"RJ Wyatt","year":"1995","unstructured":"Wyatt RJ, Henter I. An economic evaluation of manicdepressive illness: 1991. Soc Psychiatry Psychiatr Epidemiol 1995; 30: 213\u20139","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"28070555_CR39","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/S0006-3223(00)00909-4","volume":"48","author":"J Angst","year":"2000","unstructured":"Angst J, Sellaro R. Historical perspectives and natural history of bipolar disorder. Biol Psychiatry 2000; 48: 445\u201357","journal-title":"Biol Psychiatry"},{"key":"28070555_CR40","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4088\/JCP.v63n0502","volume":"63","author":"J Scott","year":"2002","unstructured":"Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry 2002; 63: 384\u201390","journal-title":"J Clin Psychiatry"},{"key":"28070555_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/NMD.0b013e31819292a6","volume":"197","author":"I Rossum van","year":"2009","unstructured":"van Rossum I, Boomsma M, Tenback D, et al. Does cannabis use affect treatment outcome in bipolar disorder? A longitudinal analysis. J Nerv Ment Dis 2009; 197: 35\u201340","journal-title":"J Nerv Ment Dis"},{"key":"28070555_CR42","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4088\/JCP.v59n0106","volume":"59","author":"CA Zarate Jr","year":"1998","unstructured":"Zarate Jr CA, Narendran R, Tohen M, et al. Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry 1998; 59: 24\u20138","journal-title":"J Clin Psychiatry"},{"key":"28070555_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.4088\/JCP.v61n0307","volume":"61","author":"CA Zarate Jr","year":"2000","unstructured":"Zarate Jr CA, Rothschild A, Fletcher KE, et al. Clinical predictors of acute response with quetiapine in psychotic mood disorders. J Clin Psychiatry 2000; 61: 185\u20139","journal-title":"J Clin Psychiatry"},{"issue":"Suppl.14","key":"28070555_CR44","first-page":"34","volume":"62","author":"JR Calabrese","year":"2001","unstructured":"Calabrese JR, Shelton MD, Bowden CL, et al. Bipolar rapid cycling: focus on depression as its hallmark. J Clin Psychiatry 2001; 62 Suppl. 14: 34\u201341","journal-title":"J Clin Psychiatry"},{"key":"28070555_CR45","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.pnpbp.2009.03.034","volume":"33","author":"J Hong","year":"2009","unstructured":"Hong J, Windmeijer F, Novick D, et al. The cost of relapse in patients with schizophrenia in the European SOHO (Schizophrenia Outpatient Health Outcomes) study. Prog Neuropsychopharmacol Biol Psychiatry 2009; 33: 835\u201341","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"28070555_CR46","volume-title":"Mental health policy and practice across Europe: the future direction of mental health care","author":"L Magliano","year":"2007","unstructured":"Magliano L, McDaid D, Kirkwood S, et al. Carers and families of people with mental health problems. In: Knapp M, McDaid D, Mossialos E, et al., editors. Mental health policy and practice across Europe: the future direction of mental health care. Maidenhead: Open University Press, 2007"},{"key":"28070555_CR47","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1176\/ps.50.10.1303","volume":"50","author":"GE Simon","year":"1999","unstructured":"Simon GE, Unutzer J. Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatr Serv 1999; 50: 1303\u20138","journal-title":"Psychiatr Serv"},{"key":"28070555_CR48","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11920-005-0069-5","volume":"7","author":"AM Kilbourne","year":"2005","unstructured":"Kilbourne AM. The burden of general medical conditions in patients with bipolar disorder. Curr Psychiatry Rep 2005; 7: 471\u20137","journal-title":"Curr Psychiatry Rep"}],"container-title":["PharmacoEconomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2165\/11535200-000000000-00000.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.2165\/11535200-000000000-00000\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.2165\/11535200-000000000-00000.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T21:39:35Z","timestamp":1685569175000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.2165\/11535200-000000000-00000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":48,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["28070555"],"URL":"https:\/\/doi.org\/10.2165\/11535200-000000000-00000","relation":{},"ISSN":["1170-7690","1179-2027"],"issn-type":[{"value":"1170-7690","type":"print"},{"value":"1179-2027","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}